Lifespan participating in Phase 3 clinical trial of Novavax vaccine

LIFESPAN CORP. is vaccinating trial participants in the Phase 3 clinical trial for the Novavax Inc. vaccine against COVID-19. /COURTESY LIFESPAN
PROVIDENCE – Lifespan Corp. began vaccinating volunteer participants this week as one of 110 host sites in the Phase 3 clinical trial for the Novavax Inc. vaccine against COVID-19. Lifespan will help with the trial by signing up volunteers and giving them either the vaccine or the placebo, then tracking their responses over a two-year…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display